Hear From Some of the Best Minds in Distribution
Find the latest in healthcare distribution topics and industry thought leadership, from the perspectives of HDA – written with the greater industry in mind.
The Pending NDC and Barcode Rule: Healthcare IT Company Perspectives
November 27, 2023
With the Food and Drug Administration’s (FDA) final rule covering amendments to its National Drug Code (NDC)1 and barcode rules anticipated in early 2024, it is essential for organizations throughout the supply chain to prepare for this regulation.
We continue our review of comments to the FDA’s proposal by summarizing responses submitted by organizations within the healthcare IT industry.
Driving the Future of the Healthcare Supply Chain
November 20, 2023
The Milken Institute’s 2023 Future of Health Summit brought together policymakers, patient advocates, healthcare workers and other leading public health experts to discuss critical issues shaping the healthcare landscape. As part of the event, Kirk Kaminsky, HDA Chairman and McKesson President of U.S. Pharmaceutical, joined panelists to discuss the future of the healthcare supply chain.
Advocacy in Action: KeySource Capitalizes on Congressional Recess To Meet with Rep. Landsman
September 26, 2023
On August 25, HDA member KeySource hosted Congressman Greg Landsman (D-Ohio) and his staff at the company’s distribution center in Cincinnati, Ohio. KeySource CEO and HDA Board Member Albert Paonessa, III, and his team — including CFO Ryan Sevek, Fulfillment Vice President Thom Coleman, Sr. Vice President of Legal Affairs Robert Brown and Director of Fulfillment Stacy Ives — described KeySource’s role in the pharmaceutical supply chain as a national distributor of generic products to retail pharmacies, hospitals, clinics and other sites of care.
FDA, Industry Experts Urge DSCSA Action at HDA’s 2023 Traceability Seminar
September 06, 2023
HDA convened more than 400 healthcare supply chain stakeholders, technology experts and regulatory officials for the association’s Traceability Seminar. This highly anticipated event provided a forum to discuss implementation challenges and strategies for Drug Supply Chain Security Act (DSCSA) compliance as the industry faced a November 27, 2023, deadline to establish a framework to trace pharmaceuticals across the supply chain.
Advocacy in Action: Mutual Drug Meets With Rep. Foushee, Pharmacy Community About Industry Priorities
August 21, 2023
During the past few months, HDA member Mutual Drug has been actively involved in advocacy and supply chain partner discussions to underscore the value of pharmaceutical distributors and to provide perspective on policy issues affecting the supply chain.
Learn more about the company's tour with Representative Valerie Foushee (D-N.C.-04) at its headquarters in Durham, N.C. and their mid-July summit held in Durham focused on state and federal legislative issues impacting independent pharmacies.
The Pending NDC and Barcode Rule: Dispenser Perspectives
August 09, 2023
With less than six months before the Food and Drug Administration (FDA) anticipates posting an amendment to its National Drug Code (NDC),1 supply chain partners are preparing for this immense change. HDA is continuing dialogue around this impactful regulation — that could cost wholesale distributors hundreds of millions of dollars to implement and maintain.
In this next installment of our series assessing supply chain sector comments, we review feedback from dispenser trade groups and other community members.